COVID-19 Vaccinations Total 676,587... 313 Completed Second Dose (Comprehensive)

[Asia Economy Reporter Seolgina Jo] Since the start of COVID-19 vaccination in Korea, a total of 676,587 people have completed their first dose over 23 days. This accounts for 84.6% of the priority vaccination target group for February and March. Among them, 313 people have completed the second dose of the Pfizer vaccine.

The COVID-19 Vaccination Response Promotion Team announced on the 21st at midnight that an additional 939 people received the vaccine. The cumulative total reached 676,587, with a vaccination rate of 84.6% among the priority target group. Among the vaccinated, 619,100 received the AstraZeneca vaccine, and 57,487 received the Pfizer vaccine. The vaccination rate compared to the domestic population (52 million) is about 1.30%.

By vaccination institution, in nursing hospitals, 177,873 people, which is 87.8% of the total 202,660 target, have been vaccinated. In nursing facilities, 96,040 people (89.0%), first responders 54,628 people (72.6%), and hospital-level or higher medical institutions 290,297 people (82.3%) have completed their first dose. Additionally, among 265 vaccination targets traveling abroad for essential activities such as official business trips or economic activities, 262 people (98.9%) have been vaccinated.

Looking at the number of vaccinated people by region for the previous day, Incheon had the highest number with 382 people. This was followed by Daegu with 223, Daejeon 194, Gyeonggi 59, Busan 46, Seoul 13, Chungnam 12, and Jeonbuk 10.

The government is currently conducting vaccinations with initial supplies of AstraZeneca and Pfizer vaccines. Both vaccines require two doses. The AstraZeneca vaccine’s second dose is administered after 10 weeks, and the Pfizer vaccine’s after 3 weeks. Starting from the previous day, the second dose began for first-dose recipients of the Pfizer vaccine, including workers at COVID-19 treatment hospitals.

The number of second-dose recipients on the previous day was 313. By region, Seoul had 275, Incheon 22, and Gyeonggi 16.

The Promotion Team reported that as of that day, the number of suspected adverse reactions reported after COVID-19 vaccination increased by 25 cases, totaling 9,782 cases.

Specifically, common post-vaccination symptoms such as muscle pain, headache, fever, chills, and nausea (including 25 new cases, totaling 9,666) accounted for the majority. Additionally, there were 89 suspected anaphylaxis cases, 11 suspected severe cases such as convulsions, and 16 death reports under investigation. No new death reports related to vaccination were added that day.

The Promotion Team compiles and announces vaccination and adverse reaction status daily at midnight.

This content was produced with the assistance of AI translation services.